![Frontiers | A practical guide to managing hypertension, hyperlipidemia, and hyperglycemia in patients with chronic myeloid leukemia Frontiers | A practical guide to managing hypertension, hyperlipidemia, and hyperglycemia in patients with chronic myeloid leukemia](https://www.frontiersin.org/files/Articles/1025392/fmed-09-1025392-HTML-r1/image_m/fmed-09-1025392-g001.jpg)
Frontiers | A practical guide to managing hypertension, hyperlipidemia, and hyperglycemia in patients with chronic myeloid leukemia
![Results of CML monitoring by quantitative RT-PCR (during the treatment... | Download Scientific Diagram Results of CML monitoring by quantitative RT-PCR (during the treatment... | Download Scientific Diagram](https://www.researchgate.net/publication/23258331/figure/fig1/AS:310561066766336@1451054936606/Results-of-CML-monitoring-by-quantitative-RT-PCR-during-the-treatment-with-INFa-patient.png)
Results of CML monitoring by quantitative RT-PCR (during the treatment... | Download Scientific Diagram
![Frontiers | Assessing Measurable Residual Disease in Chronic Myeloid Leukemia. BCR-ABL1 IS in the Avant-Garde of Molecular Hematology Frontiers | Assessing Measurable Residual Disease in Chronic Myeloid Leukemia. BCR-ABL1 IS in the Avant-Garde of Molecular Hematology](https://www.frontiersin.org/files/Articles/469178/fonc-09-00863-HTML-r1/image_m/fonc-09-00863-g001.jpg)
Frontiers | Assessing Measurable Residual Disease in Chronic Myeloid Leukemia. BCR-ABL1 IS in the Avant-Garde of Molecular Hematology
![Frontiers | Monitoring Chronic Myeloid Leukemia: How Molecular Tools May Drive Therapeutic Approaches Frontiers | Monitoring Chronic Myeloid Leukemia: How Molecular Tools May Drive Therapeutic Approaches](https://www.frontiersin.org/files/MyHome%20Article%20Library/458509/458509_Thumb_400.jpg)
Frontiers | Monitoring Chronic Myeloid Leukemia: How Molecular Tools May Drive Therapeutic Approaches
![Cancers | Free Full-Text | Treatment-Free Remission in Chronic Myeloid Leukemia: Can We Identify Prognostic Factors? Cancers | Free Full-Text | Treatment-Free Remission in Chronic Myeloid Leukemia: Can We Identify Prognostic Factors?](https://www.mdpi.com/cancers/cancers-13-04175/article_deploy/html/images/cancers-13-04175-g002.png)
Cancers | Free Full-Text | Treatment-Free Remission in Chronic Myeloid Leukemia: Can We Identify Prognostic Factors?
![Current monitoring policy for chronic-phase chronic myeloid leukemia... | Download Scientific Diagram Current monitoring policy for chronic-phase chronic myeloid leukemia... | Download Scientific Diagram](https://www.researchgate.net/publication/6674283/figure/fig3/AS:278637598265345@1443443788021/Current-monitoring-policy-for-chronic-phase-chronic-myeloid-leukemia-CML-patients.png)
Current monitoring policy for chronic-phase chronic myeloid leukemia... | Download Scientific Diagram
![Molecular recurrence and sustained molecular response in CML patients... | Download Scientific Diagram Molecular recurrence and sustained molecular response in CML patients... | Download Scientific Diagram](https://www.researchgate.net/publication/302058544/figure/fig2/AS:362149307273219@1463354532039/Molecular-recurrence-and-sustained-molecular-response-in-CML-patients-after-TKI.png)
Molecular recurrence and sustained molecular response in CML patients... | Download Scientific Diagram
Haematologica - Achieving a sustained deep molecular response in #ChronicMyeloidLeukemia (CML) is a prerequisite for TKI discontinuation, but is it also a biomarker for better clinical outcomes? In this review Susan Branford
![Monitoring of Minimal Residual Disease (MRD) in Chronic Myeloid Leukemia: Recent Advances TEMP - Oncology Nurse Advisor Monitoring of Minimal Residual Disease (MRD) in Chronic Myeloid Leukemia: Recent Advances TEMP - Oncology Nurse Advisor](https://www.oncologynurseadvisor.com/wp-content/uploads/sites/13/2020/06/PubAlliance061920_Fig1-718x1024.jpg)
Monitoring of Minimal Residual Disease (MRD) in Chronic Myeloid Leukemia: Recent Advances TEMP - Oncology Nurse Advisor
Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: when and for whom? | Haematologica
![Table 1 from Laboratory tools for diagnosis and monitoring response in patients with chronic myeloid leukemia. | Semantic Scholar Table 1 from Laboratory tools for diagnosis and monitoring response in patients with chronic myeloid leukemia. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6a1da8533fa234a77234b2a6f44caad836fe4334/2-Table1-1.png)